Gilead's coronavirus antiviral remdesivir gets conditional EU clearance

Remdesivir is in high demand after the intravenously-administered medicine helped to shorten hospital recovery times in a clinical trial.

Vials of investigational coronavirus disease (COVID-19) treatment drug are capped at a facility.

Vials of investigational coronavirus disease (COVID-19) treatment drug are capped at a facility.

(photo credit: GILEAD SCIENCES INC/HANDOUT VIA REUTERS)

ByREUTERS

JULY 4, 2020 15:36

RECOMMENDED STORIES

Palestinian Hamas terrorists keep guard on the day Hamas handed over deceased hostages in Khan Younis in the southern Gaza Strip February 20, 2025.

Admitting defeat? Why Hamas officials say the terror group 'lost control' of Gaza

JULY 7, 2025

Members of Hamas with the backdrop of the Gaza Strip, amid reports that Hamas has lost control of much of its territory.

'Security situation has collapsed': Hamas has lost 80% of its control over Gaza Strip

JULY 7, 2025

Sheikh Wadee' al-Jaabari.

Reporter's Notebook: 'Post' meets with top Hebron sheikh who wants to pull out of PA

JULY 6, 2025

IDF Maj.-Gen. Aviad Dagan entering a fighter jet; illustrative.

IDF cyber chief, retired Iran strategy head piloted fighter jets striking Iran

JULY 6, 2025

Hot Opinion

War doesn't end on the battlefield: Israel must better support veterans with PTSD

ByJPOST EDITORIAL

Zvika Klein

Israel's midnight strategist: How IDF chief Eyal Zamir rewired the doctrine on Iran

ByZVIKA KLEIN, YONAH JEREMY BOB

As thousands stay away, Ethiopian Israelis pay a heavy price in Gaza war

Can Donald Trump win a Nobel Peace Prize?